Navigation Links
Safe Life Adds David Dennis to Board of Directors
Date:2/10/2010

SAN DIEGO, Feb. 10 /PRNewswire/ -- Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies and products that help prevent the spread of infection and disease, today announced the appointment of David Dennis to its board of directors. An accomplished business veteran and venture capitalist with more than 25 years of experience managing finance and corporate strategy for a variety of companies, Dennis becomes the seventh member of Safe Life's distinguished board.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20091109/LA07319LOGO-b)

"I'm honored to join Safe Life's board of directors," said Dennis. "Safe Life is a company with a unique vision and a strong combination of experienced leadership and innovative product development. I am looking forward to helping the company achieve sustained growth and profitability as it continues developing cutting-edge, antimicrobial technologies and products."

Dennis is the founder of Los Angeles-based strategic consulting firm Evanston Advisors Inc. He previously served as managing director of Pacific Venture Group, a healthcare venture capital firm with a $210 million investment portfolio. During his career, Dennis also has held executive management positions at companies such as Tenet Healthcare Inc.; Donaldson, Lufkin & Jenrette Securities, Inc.; and Merrill Lynch Inc. In addition, he spent 15 years on the board of directors at Westwood One, Inc., most recently as chairman of the company's strategic review committee.

"We are very pleased to add someone with David's knowledge and breadth of experience to our board," said Richard Jaffe, chairman and CEO of Safe Life. "David's strategic input has been critical to the success of some of the most influential companies in America, and we believe he will play a key role in helping Safe Life bring its revolutionary technologies and products to the marketplace."

Dennis holds a bachelor's degree in economics and finance from San Diego State University and a master's in business administration in finance and corporate strategy from the University of California, Los Angeles. He spent four years in the U.S. Air Force, including a tour of duty in Vietnam in 1969, and three years in the Defense Attache Office at the American Embassy in Lisbon, Portugal. He was awarded a Bronze Star Medal, Joint Service Commendation Medal, and Air Force Commendation Medal in recognition of his service in the U.S. military.

About Safe Life

Safe Life Corp. is a company dedicated to developing novel antimicrobial technologies and products that help prevent the spread of infection and disease. Founded in 2006, at which time Triosyn Corp. became a wholly owned subsidiary, the company has developed a family of next-generation, NIOSH-certified respirators, including the Safe Life® A400 Series N95 respirator with antimicrobial protection and the Safe Life® T5000 Series P95 respirator with antimicrobial protection. Safe Life has more than 100 patents and patents pending. The Safe Life™ antimicrobial is an EPA-registered, solid-state antimicrobial that successfully harnesses the power of iodine, which has a nearly 200-year track record for being effective against a broad spectrum of microorganisms. Safe Life has garnered regulatory approvals, licenses, clearances and certifications from the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute for Occupational Safety and Health (NIOSH), INSPEC (EU) and Health Canada. Headquartered in San Diego, Safe Life has manufacturing facilities and operations in Williston, Vt., Mirabel QC, Canada and Ipoh, Malaysia. For more information, visit www.safelifecorp.com.

SOURCE Safe Life Corp.

RELATED LINKS
http://www.safelifecorp.com/
http://www.sflf.com/

'/>"/>

SOURCE Safe Life Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet
2. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the United States to Utilize Newly FDA-Cleared CARTO(R) 3 Navigation System
3. St. Davids South Austin Hospital Leading the Central Texas Region in Laser-Assisted Lead-Extraction Procedures
4. BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman
5. David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
6. Cancer Research David Hopes to Slay Cancer Goliath
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
8. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
9. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
10. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend
11. ADVENTRX Appoints Icahn Representative to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2017)... WARSAW, Ind. , June 13, 2017 Zimmer ... in musculoskeletal healthcare, today announced that the U.S. Food and ... Letter dated June 3, 2015 relating to its ... "The successful clearance of ... China manufacturing facility is a measure of the ...
(Date:6/9/2017)... INDIANAPOLIS , June 9, 2017 /PRNewswire/ ... diabetes. In a further effort to help spread lessons ... this condition, the International Diabetes Federation (IDF) and Eli ... come together for the second phase of the Bringing ... (BRIDGES 2), reaffirming their commitment to helping people with ...
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the ... New Orleans. This is a new, greatly improved version of the Doctor Referral teaming ... requests by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released ...
(Date:6/24/2017)... (PRWEB) , ... June 24, 2017 , ... ... Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients ... and weekends so that visits to the dentist fit into their patients’ busy ...
(Date:6/23/2017)... ... June 23, 2017 , ... By scoring 100% for fiscal ... four-star rating from premier online charity evaluator, Charity Navigator, validating ANRF's work as a ... all charities reviewed by Charity Navigator and earns ANRF a spot on their “ ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection ... denied entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger ... six years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Breast Cancer Conference from Sept. 18 to 20. , The two-day conference is ... subtype with the goal of improving patients’ lives and eliminating racial breast cancer-related ...
Breaking Medicine News(10 mins):